ipamorelin peptide use CJC-1295 Without DAC / (5mg/5mg) | Third-Party Tested | Fast UK Shipping Cjc + Ipamorelin CJC 1295 2.2 Clinical studies
Description
2.2 Clinical studies Curiously, an epidemiologic, large-scale, population-based study on 6,800,000 individuals from the database of the Korean National Health Insurance Service observed that being underweight may be a risk factor for the development of PD
Mrusek D
Stephan, P
Szczerba BM, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J, Scheidmann MC, Donato C, Scherrer R, Singer J, Beisel C, Kurzeder C, Heinzelmann-Schwarz V, Rochlitz C, Weber WP, Beerenwinkel N, Aceto N
In an animal study on the effect of medication on ageing animals, it was reported that ipamorelin had a dose-dependent effect on body weight gain in rats [5]
